Xiong Li, Xiuqin Li, Weiguo Lu, Shulan Zhang, Yan Yu, Xiaojing Chen, Zhangqian Huang, Yaxia Chen, Heng Wei, Ru Yang, Yan Lu, Jian Zou, Xing Xie, Yuejiang Ma, Zhilan Peng, Lin Lin, Xiaoyun Wan, Linjun Zhao, Zhu Cao, Shiming Lu, Su-wen Feng, Yao Jia, Shuang Li, Qifang Tian, Bingjian Lu, Huizhen Zhong, Xinyan Wang, Ding Ma, Weihong Shen, Pengyuan Liu, Xiaodong Cheng, Xinyu Wang, Fangxu Tang, and Lin Lu
// Yan Yu 1, * , Bingjian Lu 2, * , Weiguo Lu 3 , Shuang Li 4 , Xiuqin Li 5 , Xinyu Wang 3 , Xiaoyun Wan 3 , Yaxia Chen 3 , Suwen Feng 3 , Yao Jia 4 , Ru Yang 4 , Fangxu Tang 4 , Xiong Li 4 , Shulan Zhang 5 , Xinyan Wang 5 , Heng Wei 5 , Zhilan Peng 6 , Lin Lu 6 , Huizhen Zhong 7 , Linjun Zhao 7 , Zhangqian Huang 8 , Lin Lin 9 , Weihong Shen 9 , Yan Lu 3, 10 , Zhu Cao 1 , Jian Zou 1 , Yuejiang Ma 1 , Xiaojing Chen 1 , Qifang Tian 3 , Shiming Lu 11 , Pengyuan Liu 10, 12 , Ding Ma 4 , Xing Xie 3 and Xiaodong Cheng 3 1 Key Laboratory of Women’s Reproductive Health of Zhejiang Province, Women’s Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China 2 Department of Surgical Pathology, Women’s Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China 3 Department of Gynecologic Oncology, Women’s Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China 4 Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China 5 Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China 6 Department of Obstetrics and Gynecology, West China Second Hospital of Sichuan University, Chengdu, Sichuan, China 7 Department of Obstetrics and Gynecology, Ningbo Women and Children’s Hospital, Ningbo, Zhejiang, China 8 Department of Obstetrics and Gynecology, Shaoxing Women and Children Hospital, Shaoxing, Zhejiang, China 9 Zhejiang University Hospital, Zhejiang University, Hangzhou, Zhejiang, China 10 Institute for Translational Medicine School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China 11 Department of Clinical Laboratory, Women’s Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China 12 Sir Run Run Shaw Hospital School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China * These authors have contributed equally to this work Correspondence to: Xiaodong Cheng, email: chengxd@zju.edu.cn Xing Xie, email: xiex@zju.edu.cn Ding Ma, email: dma@tjh.tjmu.edu.cn Pengyuan Liu, email: pyliu@zju.edu.cn Keywords: genomics, whole-exome sequencing, complete hydatidiform mole, pathogenesis Received: March 31, 2017 Accepted: July 29, 2017 Published: September 08, 2017 ABSTRACT Complete hydatidiform mole (CHM) is a rare pregnancy-related disease with invasive potential. The genetics underlying the sporadic form of CHM have not been addressed previously, but maternal genetic variants may be involved in biparental CHM. We performed whole-exome sequencing of 51 patients with CHM and 47 healthy women to identify genetic variants associated with CHM. In addition, candidate variants were analyzed using single base extension and Matrix Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in 199 CHM patients and 400 healthy controls. We validated candidate variants using Sanger sequencing in 250 cases and 652 controls, including 205 new controls. Two single nucleotide polymorphisms, c.G48C(p.Q16H) in ERC1 and c.G1114A(p.G372S) in KCNG4 , were associated with an increased risk of CHM ( p